Workflows in pharmaceutical manufacturing are often data-hungry

Workflows in pharmaceutical manufacturing are often data-hungry, but many R&D teams are stuck working with small, noisy datasets.

Whether it’s chemical process optimization, process scale-up, or troubleshooting, chemists often don’t have the luxury of running hundreds of experiments to generate large datasets.But here’s the good news: You don’t need big data to achieve significant insights.

At ReactWise, we’ve built an AI platform with Bayesian Optimization at its core — a technique that’s well suited for small data problems.It’s designed to work with limited, high-uncertainty data, guiding chemists toward the most promising experiments faster than traditional methods.

We don’t just rely on your data — we can kickstart your process optimization by leveraging our proprietary reaction database and pre-trained models.

Our high-quality datasets, generated through high-throughput experimentation (HTE) campaigns, allow us to support clients even when they have very few data points.

What does it mean?

- Faster optimization

- More reliable predictions

- Fewer experiments needed to achieve process breakthroughs.

Imagine you’re optimizing a reaction yield. Instead of running 200+ experiments to identify the ideal temperature, solvent, and catalyst, ReactWise helps you get there in as few as 15-30 experiments.

With smart, data-driven suggestions after every experiment, we help chemists:

✅ Focus on what matters

✅ Avoid dead-end conditions

✅ Extract maximum insights from minimal data

The data scarcity problem in pharma is real — but it's solvable.

Machine learning tools like ReactWise empower R&D teams to unlock significant process improvements with the data they already have — or by leveraging our proprietary models and datasets.

If you’re struggling to optimize your reactions with limited experimental data, maybe it’s time to rethink your approach.

You don’t need exhaustive experimentation — you need smarter experimentation.

Let’s stop worrying about the lack of data and start focusing on what’s possible.